Predicting HIV transmission risk among HIV-infected patients seen in clinical settings

AIDS and Behavior

Volumn 11, Issue SUPPL. 1, 2007, Pages

  Morin, Stephen F ^a   Myers, Janet J ^a   Shade, Starley B ^a   Koester, Kimberly ^a   Maiorana, Andre ^a   Rose, Carol Dawson ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical settings; HIV prevention with positives; Transmission risk

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; DRUG USE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIMARY HEALTH CARE; RISK ASSESSMENT; SEXUAL BEHAVIOR; STATISTICAL ANALYSIS; SUBSTANCE ABUSE; VIRUS TRANSMISSION;

ADULT; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34548220010     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-007-9253-4     Document Type: Article

References (29)

1. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377-381.
2. CDC (2003). Advancing HIV Prevention: Interim Technical Guidance for Selected Interventions. Atlanta: CDC.
3. Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., et al. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men. Journal of Urban Health, 82(1 Suppl 1), i62-i70.
4. Colfax, G. N., Vittinghoff, E., Grant, R., Lum, P., Spotts, G., & Hecht, F. M. (2007). Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS, 21(2), 239-241.
5. Ellis, R. J., Childers, M. E., Cherner, M., Lazzaretto, D., Letendre, S., & Grant, I. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 188(12), 1820-1826.
6. Fisher, J. D., Cornman, D. H., Osborn, C. Y., Amico, K. R., Fisher, W. A., & Friedland, G. A. (2004). Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S78-87.
7. Gribble, J. N., Miller, H. G., Rogers, S. M., & Turner, C. F. (1999). Interview mode and measurement of sexual behaviors: methodological issues. Journal of Sex Research, 36, 16-24.
8. Halkitis, P. N., Parsons, J. T., & Stirratt, M. J. (2001). A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41(2), 17-35.
9. Health Resources and Services Administration HIV/AIDS Bureau. (2004). Ryan White CARE Act Data Summery. Rockville: MD August 2006.
10. Hinkin, C. H. et al. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185-194.
11. Institute of Medicine (2001). No time to lose: getting more from HIV prevention. Washington, DC: National Academy of Sciences.
12. Kalichman, S. C., Rompa, D., & Cage, M. (2005). Group intervention to reduce HIV transmission risk behavior among persons living with HIV/AIDS. Behavior Modification, 29(2), 256-285.
13. Kalichman, S. C., Rompa, D., Cage, M., DiFonzo, K., Simpson, D., Austin, J., et al. (2001). Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine, 21(2), 84-92.
14. Koblin, B. A., Chesney, M. A., Husnik, M. J., Bozeman, S., Celum, C. L., Buchbinder, S., et al. (2003). High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. American Journal of Public Health, 93(6), 926-932.
15. Lyles, C. M. et al. (2007). Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004. American Journal of Public Health, 97(1), 133-143.
16. Morin, S. F., Koester, K. A., Steward, W. T., Maiorana, A., McLaughlin, M., Myers, J. J., et al. (2004). Missed Opportunities: Prevention With HIV-Infected Patients in Clinical Care Settings. Journal of Acquired Immune Deficiency Syndromes, 36(4), 960-966.
17. Morin, S. F., Steward, W. T., Charlebois, E. D., Remien, R. H., Pinkerton, S. D., Johnson, M. O., et al. (2005). Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. Journal of Acquired Immune Deficiency Syndromes, 40(2), 226-235.
18. Myers, J. J., Steward, W. T., Charlebois, E., Koester, K. A., Maiorana, A., & Morin, S. F. (2004). Written clinic procedures enhance delivery of HIV "Prevention With Positives" counseling in primary health care settings. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S95-S100.
19. Purcell, D. W. et al. (2004). Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S110-118
20. Richardson, J. L., Milam, J., McCutchan, A., Stoyanoff, S., Bolan, R., Weiss, J., et al. (2004). Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS, 18(8), 1179-1186.
21. Rotheram-Borus, M. J., Swendeman, D., Comulada, W. S., Weiss, R. E., Lee, M., & Lightfoot, M. (2004). Prevention for Substance-Using HIV-Positive Young People: Telephone and In-Person Delivery. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S68-77.
22. Steward, W. T., Koester, K. A., Myers, J. J., & Morin, S. F. (2006). Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings. AIDS and Behavior, 10(1), 3-12.
23. The Healthy Living Project Team (2007). Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. Journal of Acquired Immune Deficiency Syndromes, 44(2), 213-221.
24. Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonenstein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science, 280(5365), 867-873.
25. Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram-Borus, M. J., Kirshenbaum, S. B., Chesney, M. A., et al. (2004). HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. Journal of Acquired Immune Deficiency Syndromes, 36(5), 1057-1066.
26. Westbrook, L., & Bauman, L. (1996). Perceived stigma of HIV/AIDS: Public view. Bronx, NY: Albert Einstein College of Medicine.
27. Wingood, G. M., DiClemente, R. J., Mikhail, I., Lang, D. L., McCree, D. H., Davies, S. L., et al. (2004). A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S58-67.
28. Wolitski, R. J., Gomez, C. A., & Parsons, J. T. (2005). Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS, 19(Suppl 1), S99-109.
29. Wolitski, R. J., Parsons, J. T., Gomez, C. A., Purcell, D. W., Hoff, C. C., & Halkitis, P. N. (2005). Prevention with gay and bisexual men living with HIV: rationale and methods of the Seropositive Urban Men's Intervention Trial (SUMIT). AIDS, 19(Suppl 1), S1-11.